Apollo Hospitals Q2 FY27 results: what the company reported
Apollo Hospitals Enterprise Limited, the Chennai-based hospital group, filed its unaudited results for the quarter ended 30 September 2026 (July to September 2026, called Q2 FY27) with NSE on the evening of 4 November 2026, after a board meeting held the same day.
Published 6 November 2026 · Potoos Research Services
In short. For July to September 2026, Apollo Hospitals reported consolidated revenue from operations of Rs 76,149 million (about Rs 7,615 crore) from continuing operations, up +23.0% from Rs 61,888 million a year earlier. Profit attributable to its owners was Rs 6,299 million (about Rs 630 crore), up +32.0% from Rs 4,772 million. Two businesses the group has sold are now shown separately, as discontinued operations.
The numbers
The first two tables are consolidated, from the company’s statement of consolidated results. Apollo Hospitals reports in Rs million, so the figures are copied as filed; ten million make one crore, so Rs 76,149 million is Rs 7,614.9 crore. The change column is worked out by us from the filing’s own numbers.
This quarter the statement is split into continuing and discontinued operations. The discontinued part is two businesses that its subsidiary Apollo Health and Lifestyle Limited has sold: Apollo Specialty Hospitals Private Limited and Apollo Fertility Centre Private Limited. Their revenue and costs are left out of the continuing lines and shown as one profit or loss line. Last year’s figures were re-presented the same way, so the two years compare like with like.
| Item | Jul to Sep 2026 | Jul to Sep 2025 | Change |
|---|---|---|---|
| Revenue from operations (continuing operations) | 76,149 | 61,888 | +23.0% |
| Total income (continuing operations) | 76,597 | 62,433 | +22.7% |
| Profit before tax (continuing operations) | 9,033 | 6,813 | +32.6% |
| Profit after tax from continuing operations | 6,584 | 5,006 | +31.5% |
| Profit or loss after tax from discontinued operations | 11 | (66) | not meaningful |
| Profit after tax for the period (both together) | 6,595 | 4,940 | +33.5% |
| Profit attributable to owners of the parent | 6,299 | 4,772 | +32.0% |
| EPS from continuing operations, basic (Rs) | 43.74 | 33.51 | +30.5% |
| Item | Apr to Sep 2026 | Apr to Sep 2025 | Change |
|---|---|---|---|
| Revenue from operations (continuing operations) | 1,45,468 | 1,19,236 | +22.0% |
| Total income (continuing operations) | 1,46,395 | 1,20,179 | +21.8% |
| Profit after tax from continuing operations | 12,778 | 9,477 | +34.8% |
| Profit after tax for the period (both together) | 12,699 | 9,350 | +35.8% |
| Profit attributable to owners of the parent | 12,106 | 9,100 | +33.0% |
| EPS from continuing operations, basic (Rs) | 84.74 | 63.90 | +32.6% |
There were no exceptional items in the quarters or half years shown. Of the quarter’s total profit of Rs 6,595 million, Rs 296 million belonged to outside shareholders in subsidiaries Apollo does not fully own (non-controlling interest). For the half year, the discontinued operations made a loss after tax of Rs 79 million, against a loss of Rs 127 million a year earlier. EPS from discontinued operations was Rs 0.08 for the quarter, against minus Rs 0.31. EPS is not annualised.
Against the previous quarter (April to June 2026), consolidated revenue from operations was higher: Rs 76,149 million against Rs 69,319 million, a change of +9.9%. Profit attributable to owners was Rs 6,299 million against Rs 5,807 million, a change of +8.5%.
Apollo Hospitals Enterprise Limited on its own (standalone)
Apollo also filed standalone results, for Apollo Hospitals Enterprise Limited alone without its subsidiaries. Also in Rs million, as filed:
| Item | Jul to Sep 2026 | Jul to Sep 2025 | Change |
|---|---|---|---|
| Revenue from operations | 29,029 | 23,561 | +23.2% |
| Total income | 30,143 | 24,972 | +20.7% |
| Profit after tax | 4,757 | 4,199 | +13.3% |
| EPS, basic (Rs) | 33.08 | 29.20 | +13.3% |
| Item | Apr to Sep 2026 | Apr to Sep 2025 | Change |
|---|---|---|---|
| Revenue from operations | 55,590 | 45,240 | +22.9% |
| Total income | 57,175 | 46,976 | +21.7% |
| Profit after tax | 8,607 | 7,268 | +18.4% |
| EPS, basic (Rs) | 59.86 | 50.55 | +18.4% |
What the company said
These are the company’s own words, from the press release it filed with NSE on 4 November 2026, inside the same document as the results.
“I am encouraged by the progress we are making across our businesses and the contribution each one of our hospitals are making to the Group.”
Dr. Prathap C. Reddy, Founder and Chairman, Apollo Hospitals Group, press release, 4 November 2026
The press release says consolidated revenue grew 23% to Rs 7,615 crore and consolidated PAT grew 32% to Rs 630 crore. Those match the filing: revenue from operations of Rs 76,149 million (+23.0%) and profit attributable to owners of Rs 6,299 million (+32.0%). Total profit including outside shareholders rose +33.5%.
The outcome letter and notes also say:
- The sale of Apollo Specialty Hospitals and Apollo Fertility Centre by Apollo Health and Lifestyle Limited, a wholly owned subsidiary, to Kids Clinic India Limited (brand name Cloudnine) was valued at an enterprise value of about Rs 15,500 million: Rs 7,650 million in cash plus an effective equity stake of about 9.9% in Kids Clinic India, valued at Rs 7,850 million. Note 8 says the divestment was completed on 12 October 2026; the outcome letter says closure was fully ensured on 3 November 2026, when the consideration was received and the shares allotted.
- The company has proposed a scheme to demerge its omni-channel pharmacy distribution and digital health businesses into Apollo Healthtech Limited, with a proposed listing of that company on NSE and BSE. The company says it has filed a petition with the National Company Law Tribunal (NCLT), and the scheme is still awaiting NCLT sanction.
- The company announced that Dr. Madhu Sasidhar’s tenure as President and CEO, Hospitals Division, is to end at the close of business hours on 14 November 2026, on completion of his employment tenure.
What the auditors said
The figures are unaudited. The statutory auditors, Deloitte Haskins & Sells LLP, carried out a limited review, which is lighter than a full audit, and the company’s notes say they expressed an unmodified review conclusion. The consolidated report says some subsidiaries and associates were reviewed by other auditors or included on figures not reviewed, and that its conclusion is not modified in respect of these matters.
Dates
- Audit Committee: 3 November 2026. Board meeting: 4 November 2026, which began at 15:20 IST.
- Filed with NSE: 4 November 2026 at 17:49 IST. The press release was filed again separately at 18:11 IST and the investor presentation at 18:47 IST.
- Dividend: none declared in this filing.
Consolidated and standalone: consolidated figures add up Apollo Hospitals Enterprise Limited and its subsidiaries, such as Apollo Health and Lifestyle, as one group, plus its share of associates and joint ventures. Standalone figures cover Apollo Hospitals Enterprise Limited alone.
Continuing and discontinued operations: when a company sells a business or decides to sell it, the accounting rules ask it to show that business separately as discontinued, in one line, so readers can see the results of the businesses it is keeping.
Owners of the parent: the part of the group’s profit that belongs to Apollo Hospitals Enterprise’s own shareholders. EPS is worked out on this part.
Rs million: ten lakh rupees. Ten million make one crore.
Q2 FY27: the second quarter of the financial year that runs from April 2026 to March 2027.
Source
- Apollo Hospitals Enterprise Limited, outcome of board meeting with unaudited standalone and consolidated results, limited review reports and press release, 4 November 2026. nsearchives.nseindia.com
This page was written by Potoos Research Services, a SEBI-registered Research Analyst (INH000027380) in Chennai. Every figure above is copied from the company’s filing or, where the page says so, from its press release. Every percentage change in the tables, and any subtotal marked as ours, is worked out by us from the filing’s own numbers.
This page reports what the company filed. It is not a recommendation to buy, sell or hold.
Common questions
What was Apollo Hospitals’ revenue in Q2 FY27?
Consolidated revenue from operations from continuing operations for July to September 2026 was Rs 76,149 million (about Rs 7,615 crore), against Rs 61,888 million in July to September 2025, a change of +23.0%. Standalone revenue, for Apollo Hospitals Enterprise Limited alone, was Rs 29,029 million, against Rs 23,561 million (+23.2%).
How much profit did Apollo Hospitals make in Q2 FY27?
Consolidated profit for the period was Rs 6,595 million, against Rs 4,940 million, a change of +33.5%. The owners’ share was Rs 6,299 million (about Rs 630 crore), against Rs 4,772 million (+32.0%). Basic EPS from continuing operations was Rs 43.74, against Rs 33.51.
What are the discontinued operations in Apollo’s results?
Apollo Specialty Hospitals and Apollo Fertility Centre, which Apollo Health and Lifestyle Limited sold to Kids Clinic India Limited (Cloudnine). Their results are shown in one line: a profit after tax of Rs 11 million in the quarter, against a loss of Rs 66 million a year earlier.
Did Apollo Hospitals declare a dividend with these results?
No dividend was declared in the 4 November 2026 results filing.
Is this page a recommendation?
No. It reports what the company filed. It is not a recommendation to buy, sell or hold.